Status:
ACTIVE_NOT_RECRUITING
The Impact of Pharmaceutical Care on the Infection Control Measures Among Hemodialytic Patients
Lead Sponsor:
University of Sulaimani
Conditions:
Infection
Hemodialysis Patients
Eligibility:
All Genders
Phase:
NA
Brief Summary
The study aims to assess the effectiveness of pharmaceutical care in reducing infection rates among hemodialysis patients with central venous (CV) lines. It will evaluate the role of clinical pharmaci...
Detailed Description
This interventional randomized controlled trial aims to investigate the impact of clinical pharmacist intervention on infection control measures among hemodialysis patients. A total of 70 patients wil...
Eligibility Criteria
Inclusion
- Patients in dialysis center with CKD
- Patients that can communicate with the researcher.
Exclusion
- The patients who are not willing to participate in this study are going to be excluded.
Key Trial Info
Start Date :
November 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 15 2025
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT06968754
Start Date
November 1 2024
End Date
May 15 2025
Last Update
May 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shar Hospital
Sulaymaniyah, Sulaymaniyah Governorate, Iraq, 46000